logo

Search

Login | Create Account

oncology


Categories

Blood Breast cancer Cancer care Childhood cancers End-of-life care Endocrine GI cancer GU cancer Head and neck cancer Lung cancer Medicines Medicopolitical Melanoma Podcasts Radiation oncology Research Risk Factors Sarcoma

Other

Conferences

Specialties


Cardiology Dermatology Endocrinology Gastroenterology Haematology Neurology Oncology Respiratory Rheumatology

General


Contact Us About Us Website Disclaimer Privacy Policy Terms & Conditions

©2022 the limbic

logo

AACR 2021

Thursday 1st - Thursday 1st January 1970

Watch on demand: AACR 2021: Highlights through an Australian lens

Last night we hosted a webinar featuring an expert panel discussing highlights from the 2021 virtual meeting of the American Association for Cancer Research, and the potential for transforming clinical practice in Australia. If you didn't get the chance to...

Last night we hosted a webinar featuring an expert panel discussing highlights from the 2021 virtual meeting of the American...


Research

Pembrolizumab monotherapy effective in cSCC: results from AACR21

Pembrolizumab monotherapy has shown robust and durable antitumour activity and promising survival data in both locally advanced and recurrent/metastatic cutaneous SCC, according to an Australian oncologist. Speaking at the American Association for Cancer Research (AACR) meeting, Dr Brett Hughes presented an...

Pembrolizumab monotherapy has shown robust and durable antitumour activity and promising survival data in both locally advanced and recurrent/metastatic cutaneous...


Cancel
Cancel